Life-Sciences-Asia.com
The Asian Life Sciences Web Portal

This is a free web portal for the life sciences in Asia... » read more

Recipharm: Marc Funk Moves to BoD; Greg Behar New CEO (2023-11-21)
Recipharm, a leading, global player in the pharmaceutical CDMO industry, announces today the appointment of Greg Behar as Chief Executive Officer. Marc Funk, who successfully led Recipharm into its next phase of growth, will join the Board of Directors, where he wi...
Legend Biotech Licenses CAR-T Therapies to Novartis (2023-11-13)
> The deal with Novartis seeks to advance Legend Biotech’s autologous CAR-T cell therapy candidate, LB2102, and other potential CAR-T cell therapies targeting Delta-like ligand protein 3 (DLL3), using the Novartis next-generation T-Charge™ CAR-T cell therapy platfo...
Kynexis Launches with €57m Series A & License from MTPC (2023-11-07)
> Lead Candidate KYN-5356, a First-In-Class Small Molecule KAT-II Inhibitor, Advancing Toward the Clinic for Cognitive Impairment Associated With Schizophrenia > €57 Million Series A Led by Forbion > Kees Been Joins as Chief Executive Officer and Jens Wendlan...
Inari Medical to Acquire LimFlow for up to $451m (2023-11-01)
LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has entered into a definitive agreement to be acquired...
Burning Rock & Boehringer Partner for Oncology CDx (2023-10-31)
On October 25, 2023, during the 2023 Boehringer Ingelheim China R&D Day event, Burning Rock and Boehringer Ingelheim officially signed the Master Service Agreement (MSA) in the field of oncology companion diagnostics. This agreement aims to provide Chinese patients...
Danaher Promotes Christopher Riley to EVP for Biotechnology (2023-10-31)
Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility...
Merck: Strategic Partnership with Hengrui [no US, CA, UK] (2023-10-30)
Not intended for US-, Canada- or UK-based media > Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and commercialize Claudin18.2 antibody-drug conjugate SHR-A1904 ...
Abingworth: $356m Clinical Co-Development Co-Investment Fund (2023-10-30)
Abingworth extends its capital base for late-stage clinical programs with pharma and biotech partners Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of ...
Caris Life Sciences & Moderna Announce Strategic Partnership (2023-10-24)
Partnership enables Moderna to leverage Caris’ vast library of de-identified, multi-modal data and analytics capabilities to accelerate precision medicine and the delivery of novel medicines to patients Caris Life Sciences® (Caris), the leading next-generation...
OrbiMed Raises $4.3b Across Private Investment Funds (2023-10-24)
OrbiMed, a global healthcare investment firm, is pleased to announce it has raised more than $4.3 billion in commitments for its latest private investment funds, including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportun...

Life-Sciences-Asia.com is your doorway to the Asian life sciences!

[LSA] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Asian region.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Germany!

» Start here with the latest News!

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]